PHAXIAM Therapeutics S.A. (PHXM) — Capital Reinvestment Ratio

Latest as of December 2012: 0.08x

PHAXIAM Therapeutics S.A. (PHXM) has a Capital Reinvestment Ratio of 0.08x as of December 2012, meaning it reinvests 0% of its operating cash flow (€621.40K) in capital expenditures (€48.40K). Check tangible equity quality of PHAXIAM Therapeutics S.A. to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

€621.40K
EUR

Capital Expenditures

€48.40K
EUR

Data as of

Dec 2012
Most recent filing

PHAXIAM Therapeutics S.A. Capital Reinvestment Ratio (2012–2012)

This chart tracks PHAXIAM Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of PHAXIAM Therapeutics S.A..

Annual Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. (2012–2012)

Year-by-year Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. from 2012 to 2012. See PHXM cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2012 0.08x €621.40K €52.50K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow